VeonGen Therapeutics | Finanzwire

Basculer en Français

9979	Companies
202294	Keywords
132920	Articles
107424	Press releases

Home
Companies
VeonGen Therapeutics

BRIEF

published on 08/21/2025 at 14:05, 6 months 14 days ago

VeonGen Therapeutics Secures FDA RMAT Designation for VG801 in Stargardt Disease

VeonGen Therapeutics Stargardt Disease VG801 Gene Therapy FDA RMAT Designation ABCA4 Gene
PRESS RELEASE

published on 08/21/2025 at 14:00, 6 months 14 days ago

VeonGen Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for VG801 Gene Therapy for Stargardt Disease
VeonGen Therapeutics receives FDA RMAT designation for VG801 gene therapy targeting Stargardt Disease, a milestone in genetic medicine development

Genetic Medicine VeonGen Therapeutics Stargardt Disease VG801 Gene Therapy FDA RMAT Designation
BRIEF

published on 06/05/2025 at 14:05, 8 months 29 days ago

VeonGen Therapeutics Rebrands and Advances Gene Therapy for Stargardt Disease

Clinical Trials Gene Therapy FDA Designation VeonGen Therapeutics Stargardt Disease
PRESS RELEASE

published on 06/05/2025 at 14:00, 8 months 29 days ago

ViGeneron Rebrands as VeonGen Therapeutics and Announces FDA Rare Pediatric Disease Designation and Clinical Progress for Lead Gene Therapy VG801 in Stargardt Disease
VeonGen Therapeutics (formerly ViGeneron) announces FDA Rare Pediatric Disease Designation and clinical progress for lead gene therapy VG801 in Stargardt Disease, advancing genetic medicine in ophthalmology and beyond

Gene Therapy Clinical Progress VeonGen Therapeutics Stargardt Disease FDA Rare Pediatric Disease Designation

Accesswire

Published on 03/05/2026 at 13:40, 16 minutes ago

Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences
Published on 03/05/2026 at 13:30, 26 minutes ago

Vox Royalty Provides 2026 Guidance and Increases Quarterly Dividend
Published on 03/05/2026 at 13:30, 26 minutes ago

Nextech3D.ai Expands AI Event Technology Into New Markets and Implements 20%-30% Enterprise Price Increase
Published on 03/05/2026 at 13:00, 56 minutes ago

Revolve Signs Definitive Agreements for Portfolio of 16 Distributed Generation Solar Projects in Mexico
Published on 03/05/2026 at 13:00, 56 minutes ago

Field Work Identifies New Mineralized Trend and Additional Gold Targets at Golden Rose

View all ACCESSWIRE

EQS Group

Published on 03/05/2026 at 13:43, 13 minutes ago

Healthcare specialist SHS Capital exits AMW, a leading specialty pharma company, and continues partnership by reinvesting with its current fund as part of a syndicate of investors
Published on 03/05/2026 at 13:25, 31 minutes ago

Huawei and SOLUM Unveil Shop-in-Shop Smart Converged Network Solution to Accelerate Retail Intelligence
Published on 03/05/2026 at 13:06, 49 minutes ago

HENSOLDT acquires Nedinsco and expands its European presence
Published on 03/05/2026 at 13:05, 51 minutes ago

Norgine announces £23 million new investment as part of more than £50 million committed to expanding medicines manufacturing in Wales
Published on 03/05/2026 at 13:00, 56 minutes ago

Huawei Launches AI Data Platform to Bridge Models and Business Value

Les Echos

Published on 03/05/2026 at 13:20, 36 minutes ago

Voting rights
Published on 03/05/2026 at 07:30, 6 hours 26 minutes ago

Share buyback finalized
Published on 03/04/2026 at 23:50, 14 hours 6 minutes ago

Total number of voting rights and shares making up the share capital at February 28, 2026
Published on 03/04/2026 at 18:00, 19 hours 56 minutes ago

Disclosure of Share Capital and Voting Rights as of February 28, 2026
Published on 03/04/2026 at 17:45, 20 hours 11 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE